Stay updated with breaking news from Protein Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and Nonagen Bioscience today announced an agreement for R&D Systems, a Bio-Techne brand, to exclusively...
Zacks Investment Research downgraded shares of Bio-Techne (NASDAQ:TECH – Get Rating) from a buy rating to a hold rating in a research report released on Wednesday, Zacks.com reports. According to Zacks, “Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as […]
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2022. Third Quarter FY2022...
Bio-Techne (NASDAQ:TECH – Get Rating) was downgraded by stock analysts at Wells Fargo & Company from an “equal weight” rating to an “underweight” rating in a report issued on Monday, The Fly reports. They currently have a $370.00 price objective on the biotechnology company’s stock, down from their previous price objective of $400.00. Wells Fargo […]
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, May 4, 2022, at...